Decitabine
Nucleoside Metabolic Inhibitor
NADAC/unit
N/A
No Shortage
16 Manufacturers
16 ANDAs
Decitabine interferes with DNA synthesis to slow cancer cell or viral replication.
Active Shortages
2026-02-20 Discontinuation of the manufacture of the drug, Ingenus Pharmaceuticals LLC
2026-02-20 Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug, Ingenus Pharmaceuticals LLC
Generic Manufacturers
ACCORD HEALTHCARE INCCHEMI SPADR REDDYS LABORATORIES LTDGLAND PHARMA LTDHETERO LABS LTD UNIT VIJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDMEITHEAL PHARMACEUTICALS INCMSN LABORATORIES PRIVATE LTDNIVAGEN PHARMACEUTICALS INCPHARMASCIENCE INCQILU PHARMACEUTICAL HAINAN CO LTDRELIANCE LIFE SCIENCES PRIVATE LTDSAGENT PHARMACEUTICALS INCSANDOZ INCWOCKHARDT BIO AGZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.